Mahana Therapeutics

Mahana Therapeutics is a leading provider of personalized digital therapeutics that empower people with chronic conditions to live fuller lives. The company’s first treatment, Mahana™ IBS, is the first FDA-cleared prescription digital therapy to deliver cognitive behavioral therapy (CBT) for adults with irritable bowel syndrome (IBS) and is suitable for patients with all types of IBS. Mahana is developing a robust pipeline of accessible, clinically-validated prescription digital therapies for the treatment of chronic health conditions to reduce disease burden and enrich the lives of individuals impacted by life-impacting chronic conditions. More information is available at mahana.com